Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.

By M. Kalliomäki, S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, E. Isolauri. The Lancet, 2001

2,364 citations recorded by the source corpus.

Subfields: Dermatology, Food Science, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/d8255a62666249b3f52b66d46328b8052e17dd0b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Food Science

In Molecular Biology

Citations in the corpus

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. (2007, background): “d e rm a to lo g y , a n d d ru g a ll e rg y The treatment showed no effect on sensitization, which is consistent with the results of the first prevention trial.(7) Although early sensitization predicts the development of clinical disease, several sensitized infants remain asymptomatic; hence the r”
Risk and safety of probiotics. (2015, background): “Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
Probiotics and prebiotics - Progress and challenges (2008, background): “There has been one study of pregnant women and newborns that suggests that consumption of probiotic Lactobacillus rhamnosus GG can reduce the rate of newborns having atopic dermatitis (Kalliomaki et al., 2001).”
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota (2017, background): “Chronic recurring atopic eczema is the main symptom of atopic disease during the first years of life (305).”
Early differences in fecal microbiota composition in children may predict overweight. (2008, neutral): “Allergic rhinitis (n/total [%]) 4/24 [17] 2/25 [8]”
Bacterial metabolism and health‐related effects of galacto‐oligosaccharides and other prebiotics (2007, background): “For example, lower cell numbers of bifidobacteria with reduced adhesive properties have been found in the faeces of allergic infants compared to control children (He et al. 2001; Kalliomaki et al. 2001a; Kirjavainen et al. 2002).”
Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives (2017, background): “Safety of a food product signifies the absence of any notable adverse health effects upon consumption under defined conditions (Kalliomäki et al., 2001).”
Probiotics and immunity (2009, background): “However, others were unable to confi rm a preventative effect of LGG supplementation,(124,125) and the results of primary prevention trials using other probiotics are variable and not as impressive as those obtained by Kalliomäki et al.(121) (as summarized in Table 5).”
Probiotic use in clinical practice: what are the risks? (2006, background): “Probiotic therapy has also been explored in nongastrointestinal diseases, including the treatment and prevention of atopic eczema (10, 11).”
Probiotics: an overview of beneficial effects (2002, background): “Indeed, differences in the neonatal gut microecology were recently documented as being associated with the development of atopic diseases (Kalliomäki et al. 2001a).”